Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 11/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.40 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28531066 | 0.78 | SIGMAR1 (0.45) | EPHX1SIGMAR1EPHX2KMT2AALDH1A1 | |
| SCHEMBL5610447 | 0.76 | EPHX1 (0.45) | EPHX1SIGMAR1EPHX2P2RX7KMT2A | |
| SCHEMBL5610374 | 0.76 | SIGMAR1 (0.44) | EPHX1SIGMAR1EPHX2KMT2AALDH1A1 | |
| SCHEMBL29244326 | 0.76 | EPHX1 (0.45) | EPHX1SIGMAR1EPHX2 | |
| SCHEMBL30195756 | 0.76 | SIGMAR1 (0.48) | EPHX1SIGMAR1EPHX2P2RX7ALDH1A1 | |
| SCHEMBL11447336 | 0.76 | EPHX1 (0.45) | EPHX1SIGMAR1EPHX2P2RX7KMT2A | |
| SCHEMBL28699952 | 0.74 | EPHX2 (0.39) | SIGMAR1EPHX2P2RX7KMT2AMEN1 | |
| SCHEMBL30195822 | 0.73 | HSD11B1 (0.45) | EPHX1SIGMAR1EPHX2P2RX7 | |
| SCHEMBL7168330 | 0.72 | EPHX1 (0.45) | EPHX1SIGMAR1EPHX2P2RX7KMT2A | |
| SCHEMBL11652443 | 0.72 | SIGMAR1 (0.41) | EPHX1SIGMAR1EPHX2KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040068131-A1 | (adamantyl)nP(alkyl)m(1a); (adamantyl)o(Alkyl)qP (alkylene')P(adamantyl)r(alkyl)s , wherein adamantyl bonded to phosphorus atom in position 1, or 2, useful for refining halogenoaromatics | EVONIK DEGUSSA GMBH (DE) | 2004-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040068131-A1 | (adamantyl)nP(alkyl)m(1a); (adamantyl)o(Alkyl)qP (alkylene')P(adamantyl)r(alkyl)s , wherein adamantyl bonded to phosphorus atom in position 1, or 2, useful for refining halogenoaromatics | NAPEPLD, NAPA, APBA1 | EPHX1 2739/4885SIGMAR1 901/4885EPHX2 2749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.